Related Experiment Video
Updated: Jan 21, 2026
05:53
Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
17.0K
Frailty and chronic disease
Maria B Zazzara1,2, Davide L Vetrano3,4, Angelo Carfì3,5
1Center of Aging Medicine, A. Gemelli University Polyclinic, IRCCS and Foundation, Rome, Italy - mbeatricezazzara@outlook.com.
Panminerva Medica
|August 1, 2019
Summary
Frailty and chronic diseases are interconnected, with chronic conditions contributing to frailty. Integrated care strategies are needed to manage frailty in older adults with multiple health issues.
Area of Science:
- Gerontology
- Internal Medicine
- Clinical Pharmacology
Background:
- Chronic diseases and frailty are common in aging, often treated separately despite their overlap.
- Frailty assessment is not routinely integrated into chronic disease management.
- Chronic conditions can precipitate frailty, highlighting a significant relationship.
Purpose of the Study:
- To emphasize the interconnectedness of frailty and chronic diseases in older adults.
- To advocate for the integration of frailty assessment into routine clinical practice.
- To propose a revised care pathway for elderly patients with multimorbidity and frailty.
Main Methods:
- Review of the relationship between frailty, aging, and chronic diseases.
- Analysis of frailty as a modifier of treatment risks and benefits.
- Discussion of the impact of certain medications on frailty development.
Main Results:
- Frailty is a comprehensive descriptor of complexity in older age, encompassing physical, psychological, and socioeconomic factors.
- Frailty status significantly influences the risk-benefit balance of pharmacological treatments for chronic diseases.
- Some common medications may exacerbate or induce frailty, necessitating careful prescribing.
Conclusions:
- Frailty assessment should be simple, quick, and patient-centered, considering individual priorities and social context.
- Individualized management plans and patient empowerment are crucial for improving quality of life in frail, multimorbid elderly patients.
- A distinct care pathway is necessary for older patients with both frailty and chronic diseases, requiring a reorganization of healthcare provision.
Related Concept Videos
01:22Chronic Obstructive Pulmonary Disease
2.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.3K
01:25Chronic Kidney Disease I: Introduction
596
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
596
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.6K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
01:24Chronic Kidney Disease II: Clinical Manifestations
574
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
574
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.3K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.3K